Back to Treatments

Treatment

Delamanid + Bedaquiline + Optimized Background Regimen (OBR)

1
Conditions
15
Trials
1,500
Participants
32%
Average Safety

Condition Evidence

HIV/AIDS - Extensively drug-resistant Tuberculosis

15 trials · 1,500 participants

75% effectiveness · 32% safety
Delamanid + Bedaquiline + Optimized Background Regimen (OBR) | DFDA